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Abstract
Background:  Pericardial adipose tissue (PAT) has been shown to be an independent predictor of
coronary artery disease. To date its assessment has been restricted to the use of surrogate
echocardiographic indices such as measurement of epicardial fat thickness over the right ventricular free
wall, which have limitations. Cardiovascular magnetic resonance (CMR) offers the potential to non-
invasively assess total PAT, however like other imaging modalities, CMR has not yet been validated for this
purpose. Thus, we sought to describe a novel technique for assessing total PAT with validation in an ovine
model.
Methods: 11 merino sheep were studied. A standard clinical series of ventricular short axis CMR images
(1.5T Siemens Sonata) were obtained during mechanical ventilation breath-holds. Beginning at the mitral
annulus, consecutive end-diastolic ventricular images were used to determine the area and volume of
epicardial, paracardial and pericardial adipose tissue. In addition adipose thickness was measured at the
right ventricular free wall. Following euthanasia, the paracardial adipose tissue was removed from the
ventricle and weighed to allow comparison with corresponding CMR measurements.
Results: There was a strong correlation between CMR-derived paracardial adipose tissue volume and ex
vivo paracardial mass (R2 = 0.89, p < 0.001). In contrast, CMR measurements of corresponding RV free wall
paracardial adipose thickness did not correlate with ex vivo paracardial mass (R2 = 0.003, p = 0.878).
Conclusion:  In this ovine model, CMR-derived paracardial adipose tissue volume, but not the
corresponding and conventional measure of paracardial adipose thickness over the RV free wall, accurately
reflected paracardial adipose tissue mass. This study validates for the first time, the use of clinically utilised
CMR sequences for the accurate and reproducible assessment of pericardial adiposity. Furthermore this
non-invasive modality does not use ionising radiation and therefore is ideally suited for future studies of
PAT and its role in cardiovascular risk prediction and disease in clinical practice.
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Background
Pericardial adipose tissue (PAT) is the layer of fat that sur-
rounds the heart. It covers 80% of the heart and consti-
tutes between 20 and 50% of its mass[1]. Historically, this
adipose layer has largely been regarded as an inert layer
that, at most, may provide some mechanical protection to
the coronary arteries[2]. More recently however, the
benign nature of this fatty tissue is being re-evaluated.
Pericardial adipose tissue is largely brown adipose tis-
sue[3] and is divided into two layers. The visceral, epicar-
dial fat layer is mainly located within the interventricular
and atrioventricular grooves, with lesser amounts located
around the atria and right ventricle. This visceral pericar-
dial layer (or epicardial layer) originates embryologically
from mesothelial cells that migrate from the septum trans-
versum and hence obtains its vascular supply from the
coronary arteries[4,5]. The paracardial fat (or mediastinal
fat) is situated external to the parietal layer of the pericar-
dium. This layer originates from the primitive thoracic
mesenchymal cells and thus derives its blood supply from
non-coronary sources such as the pericardiacophrenic
branch of the internal mammary artery[5].
Although the pathophysiological significance of PAT
remains uncertain, it has recently become the subject of
increasing attention, with emerging evidence that it may
be an independent predictor of obstructive coronary
artery disease [6-8] and possibly acute coronary syn-
drome[6]. Therefore the characterisation of PAT by non-
invasive imaging looms as a potentially valuable adjunct
in evaluating cardiovascular risk. There are several candi-
date modalities for non-invasive imaging of pericardial fat
with an ideal methodology providing robust and repro-
ducible data with high accuracy when validated against ex
vivo fat mass measurement. Transthoracic echocardiogra-
phy has traditionally been used to measure epicardial adi-
pose thickness[9], however variable image quality
remains a significant limitation particularly in obese sub-
jects: a patient cohort in whom quantification of adipose
tissue may be especially relevant. More recently, cardiac
computed tomography (CT)[8,10,11] and cardiovascular
magnetic resonance (CMR)[12] have been applied with
encouraging results. Although magnetic resonance imag-
ing is recognised as the "gold standard" modality for
imaging adipose tissue[13,14], CMR has only recently
evolved to assess adiposity around the heart[12]. The
accuracy of this methodology, however, is yet to be veri-
fied against actual measurement of ex vivo mass. In this
paper we describe a novel method of assessing complete
PAT by volume, and additionally, validate ovine paracar-
dial adipose mass collected at necropsy with its corre-
sponding CMR derived volume. Furthermore we show
that volumetric assessment of adipose tissue is a more
accurate measure of adipose tissue mass compared with
surrogates such as adipose tissue thickness at the RV free
wall.
Methods
An ovine model was chosen to allow direct comparison
between CMR-derived measurement of paracardial tissue
volume and paracardial tissue mass at necropsy. In addi-
tion, a secondary analysis was performed to determine
whether single thickness measurement of adipose tissue
over the right ventricular (RV) free wall (a parameter rou-
tinely used in echocardiographic studies) reflects an accu-
rate surrogate assessment compared to the corresponding
adipose tissue mass measured at necropsy.
Cohort
Approval was obtained from the Animal Ethics Commit-
tees of the Institute of Medical and Veterinary Services,
Adelaide and the University of Adelaide, South Australia.
Animal handling was carried out humanely by dedicated
staff in accordance with the "Principles of Laboratory
Care" formulated by the National Society for Medical
Research and the "Guide for the Care and Use of Labora-
tory Animals" prepared by the Institute of Laboratory
Research and published by the National Institutes of
Health.
All animals underwent comprehensive CMR assessment
immediately prior to euthanasia at which time heart spec-
imens were harvested for histopathological analysis.
Cardiovascular magnetic resonance protocol
Cardiovascular magnetic resonance images were acquired
using a 1.5 Tesla system (Siemens, Sonata, Erlangen, Ger-
many). Animals were anaesthetised and placed supine
within the MR chamber. The animals were mechanically
ventilated which allowed breath-hold sequences to be
obtained. Pericardial adipose tissue was assessed using
sequential ECG-gated steady state free precession short
axis cine sequences acquired for assessment of ventricular
function (TR/TE 52.05 ms/1.74 ms, flip angle 70°, matrix
256 × 150, FOV 380 mm with slice thickness 6 mm with
no inter-slice gap). To validate a clinically relevant proto-
col that is already widely used in human studies, this
study intentionally did not incorporate adipose-specific
sequences and thus did not require additional imaging
time.
Image analysis
Image analysis was carried out off-line using commer-
cially available software, Image Pro Plus (v4 MediaCyber-
netics). Areas of PAT were traced on consecutive end
diastolic short-axis images beginning with the most basal
slice at the level of the mitral valve (Figure 1) and moving
apically through the stack until the most inferior margin
of adipose tissue was traced. The basal slice was takenJournal of Cardiovascular Magnetic Resonance 2009, 11:15 http://www.jcmr-online.com/content/11/1/15
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through the mitral annulus as this was easiest point to dis-
sect at necropsy. Three traces were made on each slice as
shown in Figure 2. The first line was drawn along the myo-
epicardial border. The second line was drawn at the pari-
etal and visceral pericardial border, subtending an area of
epicardial fat between this line and the myo-epicardial
border. A third line was drawn along the outermost mar-
gin of paracardial fat. Epicardial, paracardial and subse-
quently pericardial fat areas were calculated and volumes
were derived using a modified Simpson's rule.
Pericardial adipose thickness at the mid-right ventricular
free wall was separately measured as per equivalent
echocardiographic methodology used in previous studies
evaluating pericardial adiposity[9,15]. As with volumes,
adipose thickness was sequentially determined from the
epicardial, paracardial and finally pericardial zones (Fig-
ure 2).
Intra- and interobserver variability was also assessed for
the measures of CMR PAT thickness and volumes as
described above.
Ex vivo pericardial fat assessment
The sheep were euthanased following their final CMR
examination. The hearts were surgically excised from the
thorax with particular care taken to collect all parts of
paracardial fat adherent to the mediastinal cavity. As
depicted in Figure 3, an incision was made circumferen-
tially along the atrio-ventricular groove through the peri-
cardium. Ventricular adipose tissue, not atrial adipose
tissue, was assessed as this has been previously shown to
be an independent predictor of coronary artery disease[8]
and it is known atrial PAT is only a minor contributor to
total myocardial PAT[16]. The pericardium and adherent
paracardial adipose tissue was then peeled back from the
heart in an apical direction and weighed immediately.
Only the paracardial fat was weighed as we found, like
others have before us[17] that it is virtually impossible to
accurately dissect the epicardial adipose tissue from the
myocardium. Hence correlation between the epicardial
component of PAT mass was not able to be undertaken
with its respective CMR measurement.
Statistical Analysis
Continuous variables are represented as means ± standard
deviation or medians with interquartile ranges in brackets
for data as appropriate. Statistical analyses were per-
formed with the Statistical Package for the Social Sciences
v15 (SPSS Inc, Chicago, Ill). The mass of paracardial adi-
pose tissue at necropsy was compared with the paracardial
adipose volume assessed with CMR using simple linear
regression analysis. Two sided p-values of less than 0.05
were considered statistically significant. Intra- and inter-
observer variability was assessed and data analysed with
Bland-Altman plots, and coefficients of variation.
Results
Eleven Merino sheep (49 ± 7 kg) were evaluated. CMR
imaging was successfully performed in all animals and all
images were of acceptable quality for subsequent analysis.
CMR imaging acquisition time was approximately 45
minutes per animal. There were no adverse outcomes as a
result of the CMR imaging process.
Image analysis
We were able to trace, and therefore assess, the epicardial,
paracardial (and therefore total pericardial adipose tissue)
areas in all cases. CMR measurements of adipose tissue
thickness and volumes for epicaridal, paracardial and
pericardial regions are shown in table 1. The mean CMR
derived PAT thickness was 0.856 ± 0.16 cm and the mean
CMR derived PAT volume was 103 ± 26 cm3.
Ex vivo pericardial fat assessment
In all animals, ex vivo paracardial adipose tissue was able
to be excised and weighed as described (Figure 3). Parac-
ardial adipose tissue mass was highly variable across the
eleven sheep (Table 1). The mean ex vivo mass of paracar-
dial adipose tissue in this cohort was 139 ± 49 g.
Basal and apical slice selection landmarks Figure 1
Basal and apical slice selection landmarks. Slice 
through the valve annulus was selected as basal image as this 
was easiest to approximate for dissection at necropsy.Journal of Cardiovascular Magnetic Resonance 2009, 11:15 http://www.jcmr-online.com/content/11/1/15
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Statistical Analysis
In regards to the primary hypothesis, there was a strongly
positive correlation between CMR derived paracardial adi-
pose tissue volume and ex vivo paracardial adipose mass at
necropsy (R2 = 0.89, p < 0.001) (Figure 4). Notably, nei-
ther RV free wall paracardial nor pericardial fat thickness
correlated with ex vivo PAT mass (R2 = 0.003, p = 0.878
and R2 = 0.33, p = 0.63 respectively) (Figure 5).
Intra and inter-observer coefficients of variation for CMR
PAT volumes were 3.5% and 4.9% respectively (Table 2).
The intra and inter-observer coefficients of variation for
CMR PAT thickness were higher at 6.7 and 7.6% respec-
tively (Table 2).
In assessing PAT, the reproducibility of total PAT volume
was higher than for the individual epicardial and paracar-
dial measures.
Discussion
This is the first study to describe an accurate and reproduc-
ible CMR technique that is capable of measuring not only
total PAT by volume but also its constituents, epicardial
and paracardial adipose tissue. In addition, we have
shown that CMR assessment of adipose tissue volume dis-
plays a strong correlation with its corresponding ex vivo
adipose mass, validating its use as a robust measure of car-
diac adipose tissue. Further, we have shown that conven-
tional RV free wall adipose thickness measurements do
not accurately quantify total PAT. Finally, we have
described a method for assessing PAT which intentionally
utilises image sequences that would normally be acquired
during a standard CMR protocol for myocardial structure
and function assessment. The images used were not dedi-
cated adipose-specific sequences as is the case in other
studies[9,12] and hence our methodology may be applied
to a number of clinically indicated human scans without
the need for additional imaging time.
There is growing evidence to support an important role for
PAT in the pathophysiology of cardiovascular disease.
Although there has recently been a resurgence of interest
in this area, the initial descriptions of pericardial adiposity
date back hundreds of years. Its initial association with
adverse events was described by Senac in 1783 who
described "a case of sudden death in which fat spread over
the heart extinguishing its movement"[18]. Furthermore
the diagnosis of 'adipositas cordis' was a fashionable diag-
nosis in Victorian times, although the continued associa-
tion with sudden cardiac death was more than likely
CMR evaluation of pericardial adipose tissue Figure 2
CMR evaluation of pericardial adipose tissue. Volumetric assessment: 3 traces, myo-epicardial border, viscero-parietal 
pericardial border and outer paracardial margin each subtending areas of epicardial and paracardial (and subsequently pericar-
dial) areas which can then be converted to volumes. Thickness assessment: adipose tissue thickness measured at the midpoint 
of the right ventricular free wall on the mid chamber short axis image. Epicardial (A) and paracardial (B) thickness measure-
ments depicted above.Journal of Cardiovascular Magnetic Resonance 2009, 11:15 http://www.jcmr-online.com/content/11/1/15
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related to sudden coronary thrombotic occlusion rather
than myocardial fatty infiltration[18]. It was James Her-
rick's seminal recognition of the clinical syndrome of
myocardial infarction in the early 19th century that led to
diminished interest in pericardial adiposity.
Much of the initial work performed to quantify epicardial
fat was performed at autopsy[1,17,19,20], with the epicar-
dial adipose tissue weighing on average 50 grams and thus
representing approximately 20% of the heart's mass. More
recently, echocardiography has been used to evaluate epi-
cardial fat by measuring its thickness over the RV free wall:
a prominent site for adipose tissue around the
heart[9,21]. Indeed epicardial fat thickness has been
shown to be a predictor of intra-abdominal visceral
fat[9,15], BMI[7,22], left ventricular mass[23] and insulin
resistance[24]. Despite this, our ovine study did not find
a correlation between CMR measures of RV free wall epi-
cardial or pericardial adipose thickness and the actual
mass of pericardial fat at necropsy. We acknowledge how-
ever, that there may still be some utility in using epicardial
fat thickness in ongoing research of cardiovascular risk
assessment, particularly given the accessibility and afford-
ability of transthoracic echocardiograpy compared to
CMR. However, the imperfect relationship between this
echocardiographic index and PAT, in addition to its lower
reproducibility, mean that much larger numbers of
patients will be required in such studies. Our CMR tech-
nique allows future studies of PAT to show potential alter-
ations or even changes in PAT in response to various
therapeutic interventions without the need for prohibi-
tively large sample sizes.
Removal of pericardial fat at necropsy Figure 3
Removal of pericardial fat at necropsy. A) Ovine heart in situ. B) Careful removal of heart collecting adherent fat. C) Cut-
ting through pericardium at the mitral annulus – equivalent point for CMR measurements. D) Removal of PAT from heart by 
peeling layers back apically. E) Complete removal of PAT before weighing.Journal of Cardiovascular Magnetic Resonance 2009, 11:15 http://www.jcmr-online.com/content/11/1/15
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While echocardiography has obvious benefits it also has
limitations: most notably its reliance on optimal imaging
windows which are notoriously difficult in obese
patients[25]. In one study, evaluating over 900 patients
from an outpatient echocardiography service, 14% of
obese subjects had poor echocardiographic images[26].
This is relevant given that these high-risk patients may
ultimately benefit from cardiovascular risk prediction
assessment from non-invasive characterisation of epicar-
dial and/or pericardial fat. By comparison, CMR is her-
alded for its ability to provide excellent tissue resolution
in such patients. Echocardiography is also limited in its
ability to measure the complete pericardial adipose layer
and in particular, to determine total pericardial volume.
Volumetric assessment of PAT by CT has been shown to
predict the presence of significant coronary artery dis-
ease[8] and also to be associated with left ventricular
structure and function[10] in subgroups of the Framing-
ham Heart Study. However unlike CMR, cardiac CT has
the limitation of exposing patients to ionising radiation,
which becomes an increasingly important consideration if
patients are subjected to serial imaging.
An intriguing issue that has remained unresolved in the
area of pericardial adipose assessment relates to the
Table 1: Table of CMR and necropsy measurements of PAT. Individual CMR and necropsy measurements of epicardial, paracardial 
and pericardial adipose tissue in the 11 sheep studied.
Adipose tissue thickness at mid RV Adipose tissue volume Pericardial adipose tissue mass
Epicardial (mm) Paracardial (mm) Pericardial (mm) Epicardial (cm3) Paracardial
(cm3)
Pericardial (cm3)A t  n e c r o p s y
(g)
1 5.21 3.52 8.73 27.493 56.957 84.45 99.22
2 4.62 4.28 8.9 59.37 64.56 123.93 141.68
3 4.45 4.74 9.19 49.194 61.122 110.316 142.4
4 5.63 3.81 9.44 52.836 90.852 143.688 221.2
5 3.39 4.84 8.23 38.21 65.614 103.824 145.3
6 6.08 3.91 9.99 56.521 83.723 140.244 228.3
7 5.28 5.16 10.44 21.476 57.436 78.912 91
8 5.39 4.02 9.41 34.18 57.806 91.986 125.1
9 4.18 2.25 6.43 24.552 60.252 84.804 125
10 0.81 4.07 4.88 30.036 78.144 108.18 139.4
11 4.97 3.28 8.25 19.569 40.719 60.288 72.18
CMR assessed PAT volume versus mass Figure 4
CMR assessed PAT volume versus mass. Linear regres-
sion of CMR assessed PAT volume (cm3) with ex vivo mass at 
necropsy (g). R2 = 0.892, p < 0.001.
CMR assessed PAT thickness at right ventricular free wall  versus mass Figure 5
CMR assessed PAT thickness at right ventricular free 
wall versus mass. Linear regression of CMR assessed PAT 
thickness at right ventricular free wall (cm) with ex vivo mass 
at necropsy (g). R2 = 0.334, p = 0.63.Journal of Cardiovascular Magnetic Resonance 2009, 11:15 http://www.jcmr-online.com/content/11/1/15
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importance of differentiating between the epicardial and
paracardial layers of adipose. The mechanistic relevance
of these two zones of fat appears to be quite distinct. They
have different embryological origins and vascular sup-
ply[4,5]. The epicardial fat layer expresses higher levels of
pro-inflammatory mediators than subcutaneous fat in
patients with established coronary artery disease suggest-
ing a pathophysiological relationship[27,28]. Pericardial
adipose tissue may also have a detrimental effect on the
coronary vasculature due to mechanical restriction and
impairment to diastolic coronary flow[29]. As such, the
paracardial layer may have greater importance because it
remains the main component of total PAT, as confirmed
by the current study. Further studies are required to evalu-
ate the relative clinical importance of the individual adi-
pose layers.
Limitations
Although it was necessary for this study to be performed
in animals to allow for validation of in vivo CMR against
ex vivo tissue assessment, we do not have reason to doubt
the applicability of our findings to the human clinical sce-
nario. Furthermore, we deliberately did not use pre-
defined, fat-specific imaging sequences in our CMR proto-
cols because it was our intention to utilise the exact
images which would otherwise be acquired in a routine
clinical investigation. Whilst this CMR protocol did not
utilise inter-slice gaps in the short axis stack, unpublished
data analysed in other studies[30] suggests it would be
unlikely to have a significant effect on our results.
Summary
A simple CMR volumetric technique using standard clini-
cal steady state free precession imaging is the most accu-
rate and reproducible tool currently available for the
assessment of pericardial adipose tissue. Furthermore this
non-invasive modality does not use ionising radiation
and therefore is ideally suited for future studies of pericar-
dial adipose tissue and its role in cardiovascular risk pre-
diction and disease in clinical practice.
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